Familial adenomatous polyposis-associated and sporadic pyloric gland adenomas of the upper gastrointestinal tract share common genetic features

Histopathology

Volumn 67, Issue 5, 2015, Pages 689-698

  Hashimoto, Taiki ^a   Ogawa, Reiko ^b   Matsubara, Akiko ^a   Taniguchi, Hirokazu ^a   Sugano, Kokichi ^c   Ushiama, Mineko ^b   Yoshida, Teruhiko ^b   Kanai, Yae ^b   Sekine, Shigeki ^a,b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c TOCHIGI CANCER CENTER   (Japan)

Author keywords

APC; Familial adenomatous polyposis; Fundic gland polyp; GNAS; KRAS; Pyloric gland adenoma

Indexed keywords

APC PROTEIN; BETA CATENIN; GNAS PROTEIN; K RAS PROTEIN; MUCIN 5AC; MUCIN 6; PROTEIN; UNCLASSIFIED DRUG; GNAS PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; PROTEIN P21; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COLON POLYPOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DUODENUM; FAMILIAL COLON POLYPOSIS; FEMALE; FOVEOLAR TYPE ADENOMA; FUNDIC GLAND POLYP; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; PRIORITY JOURNAL; PYLORIC GLAND ADENOMA; PYLORUS GLAND; STOMACH ADENOMA; STOMACH FUNDUS GLAND; STOMACH GLAND POLYP; STOMACH LESION; UPPER GASTROINTESTINAL TRACT; YOUNG ADULT; ADENOMA; DNA MUTATIONAL ANALYSIS; GASTRIC MUCOSA; GENETICS; IMMUNOHISTOCHEMISTRY; PATHOLOGY; POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR SUPPRESSOR GENE;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; ADULT; DNA MUTATIONAL ANALYSIS; FEMALE; GASTRIC MUCOSA; GENES, APC; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS P21(RAS); STOMACH NEOPLASMS; YOUNG ADULT;

EID: 84943361038     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12705     Document Type: Article

References (21)

1. Vieth M, Kushima R, Borchard F, Stolte M. Pyloric gland adenoma: a clinico-pathological analysis of 90 cases. Virchows Arch. 2003; 442; 317-321.
2. Vieth M, Kushima R, de Jonge JP, Borchard F, Oellig F, Stolte M. Adenoma with gastric differentiation (so-called pyloric gland adenoma) in a heterotopic gastric corpus mucosa in the rectum. Virchows Arch. 2005; 446; 542-545.
3. Kushima R, Vieth M, Borchard F, Stolte M, Mukaisho K, Hattori T. Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer 2006; 9; 177-184.
4. Chen ZM, Scudiere JR, Abraham SC, Montgomery E. Pyloric gland adenoma: an entity distinct from gastric foveolar type adenoma. Am. J. Surg. Pathol. 2009; 33; 186-193.
5. Vieth M, Kushima R, Mukaisho K, Sakai R, Kasami T, Hattori T. Immunohistochemical analysis of pyloric gland adenomas using a series of Mucin 2, Mucin 5AC, Mucin 6, CD10, Ki67 and p53. Virchows Arch. 2010; 457; 529-536.
6. Vieth M, Montgomery EA. Some observations on pyloric gland adenoma: an uncommon and long ignored entity! J. Clin. Pathol. 2014; 67; 883-890.
7. Kushima R, Sekine S, Matsubara A, Taniguchi H, Ikegami M, Tsuda H. Gastric adenocarcinoma of the fundic gland type shares common genetic and phenotypic features with pyloric gland adenoma. Pathol. Int. 2013; 63; 318-325.
8. Wood LD, Salaria SN, Cruise MW, Giardiello FM, Montgomery EA. Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms. Am. J. Surg. Pathol. 2014; 38; 389-393.
9. Nakamura Y, Nishisho I, Kinzler KW et al. Mutations of the APC (adenomatous polyposis coli) gene in FAP (familial polyposis coli) patients and in sporadic colorectal tumors. Tohoku J. Exp. Med. 1992; 168; 141-147.
10. Powell SM, Petersen GM, Krush AJ et al. Molecular diagnosis of familial adenomatous polyposis. N. Engl. J. Med. 1993; 329; 1982-1987.
11. Miyaki M, Konishi M, Kikuchi-Yanoshita R et al. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res. 1994; 54; 3011-3020.
12. Toyooka M, Konishi M, Kikuchi-Yanoshita R, Iwama T, Miyaki M. Somatic mutations of the adenomatous polyposis coli gene in gastroduodenal tumors from patients with familial adenomatous polyposis. Cancer Res. 1995; 55; 3165-3170.
13. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87(159-17).
14. Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT. Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am. J. Pathol. 2000; 157; 747-754.
15. Matsubara A, Sekine S, Kushima R et al. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. J. Pathol. 2013; 229; 579-587.
16. Lee SH, Jeong EG, Soung YH, Lee JW, Yoo NJ, Lee SH. Absence of GNAS and EGFL6 mutations in common human cancers. Pathology 2008; 40; 95-97.
17. Lauwers GY, Carneiro F, Graham DY et al. Gastric carcinoma. In Bosman FT, Carneiro F, Hruban RH, Theise ND eds. WHO classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer (IARC), 2010; 48-58.
18. Sekine S, Shimoda T, Nimura S et al. High-grade dysplasia associated with fundic gland polyposis in a familial adenomatous polyposis patient, with special reference to APC mutation profiles. Mod. Pathol. 2004; 17; 1421-1426.
19. Lee JH, Abraham SC, Kim HS et al. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am. J. Pathol. 2002; 161; 611-618.
20. Groves C, Lamlum H, Crabtree M et al. Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am. J. Pathol. 2002; 160; 2055-2061.
21. Polakis P. Wnt signaling in cancer. Cold Spring Harb. Perspect. Biol 2012; 4; a008052.